HHT: A Rare Disease with A Broad Spectrum of Clinical Aspects

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|10|1217-1220

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.10, 2006-04, pp. : 1217-1220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial [Hot Topic: Molecular and Clinical Aspects of Hereditary Hemorragic Telangiectasia: A Rare Disease Executive Editor: (Emilo Jirillo)]

By  

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1169-1170

Bentham Science Publishers

Access to resources Recommend Favorite

Hereditary Haemorrhagic Telangiectasia (HHT): Genetic and Molecular Aspects

By  

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1173-1193

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Aspects of Melatonin Intervention in Alzheimer's Disease Progression

By  

Current Neuropharmacology, Vol. 8, Iss. 3, 2010-01 ,pp. : 218-227

Bentham Science Publishers

Access to resources Recommend Favorite

Fluoxetine: broad-spectrum effect in PTSD

By  

Inpharma, Vol. 1, Iss. 1250, 2000-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Broad-spectrum rifaximin broadens its horizons

By  

Inpharma, Vol. 1, Iss. 1542, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite